| Interim scoring for the EQ-5D-5L: mapping the EQ-5D-5L to EQ-5D-3L value sets B Van Hout, MF Janssen, YS Feng, T Kohlmann, J Busschbach, D Golicki, ... Value in health 15 (5), 708-715, 2012 | 1967 | 2012 |
| Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study MF Janssen, AS Pickard, D Golicki, C Gudex, M Niewada, L Scalone, ... Quality of life research 22, 1717-1727, 2013 | 1584 | 2013 |
| A comparison of the EQ‐5D and SF‐6D across seven patient groups J Brazier, J Roberts, A Tsuchiya, J Busschbach Health economics 13 (9), 873-884, 2004 | 939 | 2004 |
| Standardised mindfulness-based interventions in healthcare: an overview of systematic reviews and meta-analyses of RCTs RA Gotink, P Chu, JJV Busschbach, H Benson, GL Fricchione, ... PloS one 10 (4), e0124344, 2015 | 848 | 2015 |
| The Dutch tariff: results and arguments for an effective design for national EQ‐5D valuation studies LM Lamers, J McDonnell, PFM Stalmeier, PFM Krabbe, JJV Busschbach Health economics 15 (10), 1121-1132, 2006 | 663 | 2006 |
| A single European currency for EQ-5D health states: results from a six-country study W Greiner, T Weijnen, M Nieuwenhuizen, S Oppe, X Badia, J Busschbach, ... The European Journal of Health Economics, formerly: HEPAC 4, 222-231, 2003 | 548 | 2003 |
| Psychological factors affecting the outcome of total hip and knee arthroplasty: a systematic review MM Vissers, JB Bussmann, JAN Verhaar, JJV Busschbach, ... Seminars in arthritis and rheumatism 41 (4), 576-588, 2012 | 514 | 2012 |
| The economic burden of personality disorders in mental health care. DI Soeteman, LH Roijen, R Verheul, JJV Busschbach Journal of Clinical Psychiatry 69 (2), 259, 2008 | 459 | 2008 |
| Validating the EQ-5D with time trade off for the German population W Greiner, C Claes, JJV Busschbach, JM Graf von der Schulenburg The European journal of health economics 6, 124-130, 2005 | 456 | 2005 |
| Critical review of generic and dermatology-specific health-related quality of life instruments H Both, ML Essink-Bot, J Busschbach, T Nijsten Journal of Investigative Dermatology 127 (12), 2726-2739, 2007 | 431 | 2007 |
| Severity Indices of Personality Problems (SIPP-118): development, factor structure, reliability, and validity. R Verheul, H Andrea, CC Berghout, C Dolan, JJV Busschbach, ... Psychological assessment 20 (1), 23, 2008 | 419 | 2008 |
| Anxiety and depressive symptoms before and after total hip and knee arthroplasty: a prospective multicentre study T Duivenvoorden, MM Vissers, JAN Verhaar, JJV Busschbach, T Gosens, ... Osteoarthritis and Cartilage 21 (12), 1834-1840, 2013 | 353 | 2013 |
| Sensitivity and perspective in the valuation of health status: whose values count? GA De Wit, JJV Busschbach, FT De Charro Health economics 9 (2), 109-126, 2000 | 276 | 2000 |
| Randomized clinical trial of non‐mesh versus mesh repair of primary inguinal hernia WW Vrijland, MP van Den Tol, RW Luijendijk, WCJ Hop, JJV Busschbach, ... British journal of surgery 89 (3), 293-297, 2002 | 273 | 2002 |
| United States valuation of EQ-5D-5L health states using an international protocol AS Pickard, EH Law, R Jiang, E Pullenayegum, JW Shaw, F Xie, M Oppe, ... Value in health 22 (8), 931-941, 2019 | 262 | 2019 |
| The multiple propensity score as control for bias in the comparison of more than two treatment arms: an introduction from a case study in mental health MD Spreeuwenberg, A Bartak, MA Croon, JA Hagenaars, ... Medical care 48 (2), 166-174, 2010 | 261 | 2010 |
| The burden of disease in personality disorders: diagnosis-specific quality of life DI Soeteman, R Verheul, JJV Busschbach Journal of personality disorders 22 (3), 259-268, 2008 | 233 | 2008 |
| The Indonesian EQ-5D-5L value set FD Purba, JAM Hunfeld, A Iskandarsyah, TS Fitriana, SS Sadarjoen, ... Pharmacoeconomics 35, 1153-1165, 2017 | 205 | 2017 |
| Factors associated with adherence to pharmaceutical treatment for rheumatoid arthritis patients: a systematic review A Pasma, A van't Spijker, JMW Hazes, JJV Busschbach, JJ Luime Seminars in arthritis and rheumatism 43 (1), 18-28, 2013 | 205 | 2013 |
| Which multi-attribute utility instruments are recommended for use in cost-utility analysis? A review of national health technology assessment (HTA) guidelines M Kennedy-Martin, B Slaap, M Herdman, M van Reenen, ... The European Journal of Health Economics 21, 1245-1257, 2020 | 203 | 2020 |